InsidersTradesSigma
Track the 클래시스 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 클래시스 has published 9 reports. Market capitalisation: €2,670.7bn. The latest transaction was filed on 13 March 2026 (Other). Among the most active insiders: BCPECenturInvestments,LP. Every trade is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 클래시스 Buy (bullish), based on 19 analysts. Average price target: ₩73,105.
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,253 of 29,064 companies
72.7
score / 100
Value56
Quality89
FCF yld5.4%
Earn yld4.9%
EV/EBITDA14.8x
ROE27%
Gross mgn78%
Net mgn39%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 March 2026
Declarations9 total
ShareKRXDART:20260227000927
4,019,400 sharesKRXDART:20260226001381
5,532,987 sharesKRXDART:20260226001437
866,036 sharesKRXDART:20241010000540
ShareKRXDART:20221117000218
9 of 9 declarations
关于 클래시스
클래시스 是一家在韩国交易所 (XKRX) 上市的医疗保健和制药公司。该公司专注于为医疗领域开发创新解决方案。